(Q40107519)

17 September 2017

1 reference

title

Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae (English)

1 reference

17 September 2017

trypanosomatidae

1 reference

J. J. Marr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192336

25 August 2023

R. L. Berens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192336

25 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6192336

25 August 2023

publication date

1 April 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0166685183900166?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

https://api.elsevier.com/content/article/PII:0166685183900166?httpAccept=text/plain

25 August 2023

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Molecular and Biochemical Parasitology

25 August 2023

published in

1 reference

17 September 2017

volume

7

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

339-356

1 reference

Purine metabolism in Leishmania donovani and Leishmania braziliensis

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

A re-examination of purine and pyrimidine synthesis in the three main forms of Trypanosoma cruzi

25 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Purine Metabolism in Trypanosomatids*

25 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Purine metabolism in Trypanosoma cruzi

25 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Inhibition of urate production by allopurinol

25 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Renal clearance of oxipurinol, the chief metabolite of allopurinol

25 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Metabolic studies of allopurinol, an inhibitor of xanthine oxidase

25 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Formation of nucleotides of (6-14C)allopurinol and (6-14C)oxipurinol in rat tissues and effects on uridine nucleotide pools

25 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Mechanism of allopurinol-mediated inhibition of pyrimidine biosynthesis

25 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Depletion of erythrocyte phosphoribosylpyrophosphate in man.

25 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Pharmacology of allopurinol

25 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antileishmanial effect of allopurinol

25 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antileishmanial effect of allopurinol

25 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antagonists of Growth Inhibition ofCrithidiaby Allopurinol, a Guanine Analog

25 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Mammalian adenylosuccinate synthetase. Nucleotide monophosphate substrates and inhibitors

25 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism

25 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Metabolism of [6-14C]allopurinol—Lack of incorporation of allopurinol into nucleic acids

25 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol

25 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

A comparison of the specificities of xanthine oxidase and aldehyde oxidase.

25 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovani

25 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Metabolic studies of thiopurinol in man and the pig

25 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Thiopurinol: dose-related effect on urinary oxypurine excretion

25 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Phosphorylation and anti-leishmanial activity of formycin B

25 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli

25 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Influence of formycin B on polyadenosine diphosphoribose synthesis in vitro and in vivo

25 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

The metabolism of formycin B in Leishmania donovani

25 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Metabolism and mechanism of action of formycin B in Leishmania

25 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Antitrypanosomal Effect of Allopurinol: Conversion in Vivo to Aminopyrazolopyrimidine Nucleotides by Trypanosoma cruzi

25 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Trypanosoma cruzi: allopurinol in the treatment of mice with experimental acute Chagas disease

25 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Differential metabolism of allopurinol and derivatives in Trypanosoma rangeli and T. cruzi culture forms

25 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents

25 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms

25 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Effect of allopurinol on different strains of Trypanosoma cruzi

25 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Trypanosoma rhodesiense: semiautomated microtesting for quantitation of antitrypanosomal activity in vitro

25 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Pyrazolopyrimidine metabolism in African trypanosomes: metabolic similarities to Trypanosoma cruzi and Leishmania spp.

25 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

Allopurinol in the treatment of visceral leishmaniasis

25 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0166-6851(83)90016-6

25 August 2023

Identifiers

1 reference

17 September 2017

1 reference